Symbol
Arbutus Biopharma Corporation
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$3.23
Current price of the stock
$2M
Trading volume of the stock
$610.5M
Market capitalization of the company
Small Cap
Category of market capitalization
-
Long-term growth mean estimate
4.50
Mean analyst rating
62.54%
Potential price appreciation based on analyst price targets
12.50%
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
7.02
Current ratio
100.00%
Gross profit margin
-1601.19%
Operating profit margin
-1601.19%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-1472.52%
Pretax profit margin
-1472.52%
Net profit margin
-18.45%
Measures profitability relative to shareholders' equity
-18.45%
ROE excluding intangible assets
-14.04%
Measures profitability relative to total assets
-18.45%
Measures profitability relative to invested capital
0.01
Asset turnover ratio
-
Inventory turnover ratio
0.83
Receivables turnover ratio
108.08
Average number of days it takes to collect receivables
-7.51
Measures valuation relative to earnings
-
P/E based on future earnings estimates
90.55
Measures valuation relative to sales
5.72
Measures valuation relative to book value
-2.95
Measures valuation relative to operating cash flow
-2.93
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
